Later generation fluoroquinolones may improve outcomes for patients with XDR-TB
Links shared publicly online about this topic.
- 1,632total visits
Later generation fluoroquinolones may improve outcomes for patients with XDR-TB
For every additional 10% of patients with extensively drug-resistant tuberculosis receiving fluoroquinolones, there may be a 4% increase in clinica
View full resource at pediatricsupersite.com
Tags: Tuberculosis
Most Recently Shared on November 2, 2009 at 4:31 pm By:
From IDSA meeting: Later generation #fluoroquinolones may improve outcomes for patients with XDR-TB: http://ow.ly/yBbp
Advertisement
